MedPath

山西利丰华瑞制药有限责任公司

Ownership
-
Established
2004-12-29
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

74

NMPA:74

Drug Approvals

Benproperibe Phosphate Tablets

Product Name
磷酸苯丙哌林片
Approval Number
国药准字H14020424
Approval Date
Mar 29, 2022
NMPA

Norfloxacin Capsules

Product Name
诺氟沙星胶囊
Approval Number
国药准字H14020427
Approval Date
Mar 29, 2022
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H14020430
Approval Date
Mar 29, 2022
NMPA

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H14022527
Approval Date
Feb 24, 2022
NMPA

Acetylspiramycin Tablets

Product Name
乙酰螺旋霉素片
Approval Number
国药准字H14020665
Approval Date
Feb 24, 2022
NMPA

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H14020176
Approval Date
Feb 24, 2022
NMPA

脑血栓片

Approval Number
国药准字Z14021643
Approval Date
Feb 24, 2022
NMPA

Trimethoprim Tablets

Product Name
甲氧苄啶片
Approval Number
国药准字H14020520
Approval Date
Sep 9, 2020
NMPA

Oxytetracycline Tablets

Product Name
土霉素片
Approval Number
国药准字H14020429
Approval Date
Aug 31, 2020
NMPA

Phenporbamate Tablets

Product Name
苯丙氨酯片
Approval Number
国药准字H14023792
Approval Date
Aug 31, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.